We are live on ! Find out more
JG

Joel Greenblatt Gotham Asset Management

AUM $43B
1-Year Est. Return 34.97%
 

Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.

This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+34.97%
3 Year Est. Return
+97.97%
5 Year Est. Return
+117.45%
10 Year Est. Return
+441.95%
AUM
$3.55B
AUM Growth
+$214M
Cap. Flow
-$46.3M
Cap. Flow %
-1.3%
Top 10 Hldgs %
22.16%
Holding
1,351
New
195
Increased
468
Reduced
530
Closed
150

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$13M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$12.6M
3
PYPL icon
PayPal
PYPL
+$11.2M
4
LRCX icon
Lam Research
LRCX
+$10.5M
5
ON icon
ON Semiconductor
ON
+$8.83M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$11.8M
2
ADBE icon
Adobe
ADBE
+$11.2M
3
PH icon
Parker-Hannifin
PH
+$9.65M
4
DIS icon
Walt Disney
DIS
+$8.9M
5
FDX icon
FedEx
FDX
+$8.85M

Sector Composition

Rank Sector Weight
1 Technology 19.16%
2 Healthcare 12.01%
3 Industrials 10.55%
4 Consumer Discretionary 10.05%
5 Financials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SENS icon
1201
Senseonics Holdings Inc
SENS
$513M
$11.7K ﹤0.01%
567
-700
-55% -$16.2K
A icon
1202
Agilent Technologies
A
$44.9B
– –
-3,393
Closed -$412K
AGNC icon
1203
AGNC Investment
AGNC
$12.9B
– –
-10,107
Closed -$85K
AIT icon
1204
Applied Industrial Technologies
AIT
$12.5B
– –
-2,284
Closed -$235K
ALKS icon
1205
Alkermes
ALKS
$8.11B
– –
-13,395
Closed -$299K
AOSL icon
1206
Alpha and Omega Semiconductor
AOSL
$798M
– –
-20,509
Closed -$631K
APLS
1207
DELISTED
Apellis Pharmaceuticals
APLS
– –
-4,458
Closed -$304K
ASH icon
1208
Ashland
ASH
$3.33B
– –
-2,702
Closed -$257K
AVIR icon
1209
Atea Pharmaceuticals
AVIR
$436M
– –
-11,431
Closed -$65K
AVXL icon
1210
Anavex Life Sciences
AVXL
$300M
– –
-16,775
Closed -$173K
BCRX icon
1211
BioCryst Pharmaceuticals
BCRX
$2.44B
– –
-24,034
Closed -$303K
BDX icon
1212
Becton Dickinson
BDX
$52.3B
– –
-2,204
Closed -$491K
BILL icon
1213
BILL Holdings
BILL
$4.76B
– –
-11,017
Closed -$1.46M
BLCO icon
1214
Bausch + Lomb
BLCO
$6.16B
– –
-12,066
Closed -$185K
BX icon
1215
Blackstone
BX
$108B
– –
-8,356
Closed -$699K
CCL icon
1216
Carnival Corporation Ltd
CCL
$35.2B
– –
-13,205
Closed -$93K
CCK icon
1217
Crown Holdings
CCK
$13B
– –
-16,584
Closed -$1.34M
CENX icon
1218
Century Aluminum
CENX
$4.35B
– –
-26,219
Closed -$138K
CHD icon
1219
Church & Dwight Co
CHD
$23.4B
– –
-14,073
Closed -$1M
CHPT icon
1220
ChargePoint
CHPT
$162M
– –
-1,077
Closed -$318K
VISN
1221
Vistance Networks Inc
VISN
$2.59B
– –
-25,000
Closed -$230K
CRON
1222
Cronos Group
CRON
$1.22B
– –
-19,152
Closed -$54K
CRUS icon
1223
Cirrus Logic
CRUS
$5.78B
– –
-12,182
Closed -$838K
CTXR icon
1224
Citius Pharmaceuticals
CTXR
$16.5M
– –
-879
Closed -$2.28M
DKNG icon
1225
DraftKings
DKNG
$13B
– –
-32,192
Closed -$487K
47 48
49
50 51

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Joel Greenblatt's Q4 2022 Portfolio in Review

As of Q4 2022, Joel Greenblatt held 1,351 positions worth $3.55B, up 6.4% from $3.34B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Joel Greenblatt's Q4 2022 filing shows 195 new, 468 increased, 530 reduced and 150 closed positions. Its largest new stake was Albemarle: 27,723 shares worth $6.01M. The largest sale was Micron Technology, an estimated $11.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Joel Greenblatt's largest Q4 2022 buy was Albemarle: 27,723 shares worth $6.01M.
  • Joel Greenblatt added most to Humana in Q4 2022, an estimated $13M increase.
  • Joel Greenblatt's biggest Q4 2022 reduction was Micron Technology, cutting an estimated $11.8M.
  • Joel Greenblatt fully exited FedEx in Q4 2022, selling an estimated $8.85M.
  • Joel Greenblatt's ten largest holdings make up 22% of its $3.55B portfolio in Q4 2022.
  • Joel Greenblatt opened 195 new positions and closed 150 in Q4 2022.
  • Joel Greenblatt's portfolio value rose 6.4% quarter-over-quarter to $3.55B.

Based on Gotham Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.